SC Pharmaceuticals Inc (SCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Sales | 16,041 | 11,752 | 12,150 | 10,026 | 8,054 |
| Cost of Goods | 5,011 | 3,471 | 3,965 | 3,311 | 2,300 |
| Gross Profit | 11,030 | 8,281 | 8,185 | 6,715 | 5,754 |
| Operating Expenses | 25,335 | 26,509 | 25,493 | 25,172 | 20,485 |
| Operating Income | -14,294 | -17,757 | -16,343 | -18,146 | -14,431 |
| Interest Expense | 1,401 | 1,385 | 1,485 | 1,850 | 2,134 |
| Other Income | -2,329 | -600 | -1,017 | -15,109 | -525 |
| Pre-tax Income | -18,024 | -19,742 | -18,845 | -35,105 | -17,090 |
| Net Income Continuous | -18,024 | -19,742 | -18,845 | -35,105 | -17,090 |
| Net Income | $-18,024 | $-19,742 | $-18,845 | $-35,105 | $-17,090 |
| EPS Basic Total Ops | -0.34 | -0.37 | -0.36 | -0.75 | -0.44 |
| EPS Basic Continuous Ops | -0.34 | -0.37 | -0.36 | -0.75 | -0.44 |
| EPS Diluted Total Ops | -0.34 | -0.37 | -0.36 | -0.75 | -0.44 |
| EPS Diluted Continuous Ops | -0.34 | -0.37 | -0.36 | -0.75 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.34 | -0.35 | -0.37 | -0.44 |
| EBITDA(a) | $-14,230 | $-17,694 | $-16,339 | $-18,233 | $-14,379 |